Current
treatment approaches for hepatocellular carcinoma (HCC)
have a narrow therapeutic index and alternate modes of treatment are
thus required. We have utilized a gene delivery vector containing
inducible caspase 9 (iCasp9) gene, which is a synthetic analogue based
on the mammalian caspase 9 and fused to a human FK506 binding protein
that allows its conditional dimerization to a synthetic, small molecule
[chemical inducer of dimerization, AP20187] and results in target
cell apoptosis. In our studies, we have tested these synthetic vectors
based on an adeno-associated virus platform for their potential anti-tumorigenic
effect in human HCC cells in vitro and in a HCC tumor
model developed in nude mice. Our data demonstrates
that the iCasp9-AP20187 bioconjugate is able to trigger terminal effectors
of cellular apoptosis and presents a viable approach for the potential
treatment of HCC.
Recombinant
adeno-associated virus (AAV)-based gene therapy has
been promising, but several host-related transduction or immune challenges
remain. For this mode of therapy to be widely applicable, it is crucial
to develop high transduction and permeating vectors that infect the
target at significantly low doses. Because glycosylation of capsid
proteins is known to be rate limiting in the life cycle of many viruses,
we reasoned that perturbation of glycosylation sites in AAV2 capsid
will enhance gene delivery. In our first set experiments, pharmacological
modulation of the glycosylation status in host cells, modestly decreased
(1-fold) AAV2 packaging efficacy while it improved their gene expression
(∼74%) in vitro. We then generated 24 mutant AAV2 vectors modified
to potentially create or disrupt a glycosylation site in its capsid.
Three of them demonstrated a 1.3–2.5-fold increase in transgene
expression in multiple cell lines (HeLa, Huh7, and ARPE-19). Hepatic
gene transfer of these vectors in hemophilia B mice, resulted in a
2-fold increase in human coagulation factor (F)IX levels, while its
T/B-cell immunogenic response was unaltered. Subsequently, intravitreal
gene transfer of glycosylation site-modified vectors in C57BL6/J mice
demonstrated an increase in green fluorescence protein expression
(∼2- to 4-fold) and enhanced permeation across retina. Subretinal
administration of these modified vectors containing RPE65 gene further
rescued the photoreceptor response in a murine model of Leber congenital
amarousis. Our studies highlight the translational potential of glycosylation
site-modified AAV2 vectors for hepatic and ocular gene therapy applications.
During recombinant Adeno-associated virus (AAV) production, a proportionately large amount of vectors is released in the culture supernatant, which is often discarded. It has been shown that these vectors often associate with vesiculated structures, such as exosomes. Exosome-associated AAV (vexosomes) represent an additional gene-delivery platform. The efficiency of such vexosomes in suicide gene therapy is unexplored. In the present study, we have generated AAV serotype 6 vexosomes containing an inducible caspase 9 (iCasp9) suicide gene by a differential ultracentrifugation-based protocol. We further tested the cytotoxic potential of these vexosomes in a human hepatocellular carcinoma (HCC) model in vitro and in vivo. The AAV6-iCasp9 containing vexosomes, when primed with a pro-drug (AP20187), demonstrated a significant loss in cell viability (57% ± 8% versus 100% ± 4.8%, p < 0.001) in comparison to mock-treated Huh7 cells. An intratumoral administration of AAV6-iCasp9 vexosomes and AP20187 in a murine xenograft model revealed a 2.3-fold increase in tumor regression in comparison to untreated animals. These findings were further corroborated by histological analysis and apoptosis assays. In conclusion, our data demonstrate the therapeutic potential of AAV6 vexosomes in a xenotransplantation model of HCC. Furthermore, the simplicity in production and isolation of vexosomes should further facilitate its application in other malignancies.
Background: Diabetes mellitus (DM) is widely spread in South Asian (ASEAN) and Indian sub-continent. The increasing healthcare costs of DM can be prevented in the developing world by improved public healthcare interventions. Modifiable risk factors of DM like sedentary lifestyle, obesity, and stressful conditions are associated with its progression; however, the epidemiological data collected by Public Institutions are limited. Summary: A review of published literature describing geographic distribution of DM and associated dementia in South Asian region, particularly India, was conducted with the purpose of assessing the feasibility and challenges associated with the Yoga-based risk reduction. PubMed and Google Scholar databases were searched for DM and dementia-related articles by using a combination of keywords: Diabetes, Diabetes related Dementia Southeast Asia, Pre-diabetes, Yoga, lifestyle modification, Dementia and Exercise. The epidemiological data generated from these diseases have not prompted to any major public health policies. Yoga can be a cost-effective intervention for the prevention of Type 2 DM (T2DM) and its associated cognitive decline when detected early. If nationwide intervention of Yoga is brought about by the state, its integration in health care will become more meaningful and acceptable. Key Message: Studies suggest that Yoga and change in lifestyle can modify the health risks associated with T2DM and associated dementia if it is mainstreamed with the public health initiative of Ayushman Bharat scheme.
Background
Repeated failure to rescue the damaged retinal ganglion cells (RGCs) by various drugs has warranted the need to screen common herbal compounds available in the form of various eye formulations for their efficacy.
Objective
We aimed to investigate the neuroprotective effect of pretreatment with aqueous extract of
A
.
cepa
in Ischemia/Reperfusion (I/R) induced retinal injury.
Methods
Ischemia was induced for 2 h by pterygopalatine artery (PPA) ligation in C57BL/6J mice, followed by reperfusion. The neuroprotective role of oral pretreatment with aqueous extract of
A. cepa
(300 mg/kg) was analyzed with respect to control and injury only group at 7, 14, and 28 day after the surgery for expression of different genes in the retina by Real-Time PCR.
Results
Molecular analysis at different time points showed increased expression of BCl-2, GDNF, GFAP, and Brn3b in the retina at 14 and 28 day after
A. cepa
treatment in comparison to the injury alone group. However, at shorter time point (7th day), the expression of these genes was pronounced in the injury only group in comparison to the injury and pretreated group.
Conclusion
Pretreatment with aqueous extract of
A. cepa
may protect from the neuronal damage in I/R-induced retinal injury in mice by altering the expression of neurotrophic factor.
Background: India is fast becoming the diabetic capital in the world according to a recent report. Patients with diabetes are at increased risk of mortality due to diabetic complications, which has enormous implications for the health budget. Objectives: The main objective of this review is to provide an overview of the work carried out in the world, including modern and traditional approaches for the prevention and management of diabetes and reducing the chances of onset of further complications via cost-effective lifestyle interventions and integrative medicine. Material and Methods: We performed a literature search from various databases like PubMed, Scopus, Google scholar, etc., using the keywords diabetes, prediabetes, MCI and prediabetes, diabetes and yoga, diabetes. Results: Upon reviewing the published articles, it was noticed that one of the most neglected complications of diabetes, namely cognitive dysfunction, which is characterized by a pattern of vascular dementia and Alzheimer disease (AD), has been largely ignored, and there has been no large study investigating the role of yoga intervention in diabetes and/or associated cognitive impairment. Conclusion: The review article opens new paradigms for researchers to evaluate the connection between diabetes and AD through a yoga-based national campaign on diabetes. This paves the way towards the goal of integrative medicine.
Diabetic retinopathy (DR) is a leading cause of blindness in working-age adults and remains an important public health issue worldwide. Here we demonstrate that the expression of stimulator of interferon genes (STING) is increased in patients with DR and animal models of diabetic eye disease. STING has been previously shown to regulate cell senescence and inflammation, key contributors to the development and progression of DR. To investigate the mechanism whereby STING contributes to the pathogenesis of DR, diabetes was induced in
STING
-KO mice and
STING
GT
(loss-of-function mutation) mice, and molecular alterations and pathological changes in the retina were characterized. We report that retinal endothelial cell senescence, inflammation, and capillary degeneration were all inhibited in
STING
-KO diabetic mice; these observations were independently corroborated in
STING
GT
mice. These protective effects resulted from the reduction in TBK1, IRF3, and NF-κB phosphorylation in the absence of STING. Collectively, our results suggest that targeting STING may be an effective therapy for the early prevention and treatment of DR.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.